Prognostic Gleason grade grouping: data based on the modified Gleason scoring system. - Wikidata - awgldk - TriplyDB

Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.

Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.

http://www.wikidata.org/entity/Q34610101

about

MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer The evolving Gleason grading system Grading of prostatic adenocarcinoma: current state and prognostic implications Active surveillance for prostate cancer: current evidence and contemporary state of practice Clinical significance of prospectively assigned Gleason tertiary pattern 4 in contemporary Gleason score 3+3=6 prostate cancer.The expanding landscape of diffusion-weighted MRI in prostate cancer Advantages of evaluating mean nuclear volume as an adjunct parameter in prostate cancer.The association between race and prostate cancer risk on initial biopsy in an equal access, multiethnic cohort Ongoing Gleason grade migration in localized prostate cancer and implications for use of active surveillance.Overexpression of the novel senescence marker β-galactosidase (GLB1) in prostate cancer predicts reduced PSA recurrence Future-proofing Gleason Grading: What to Call Gleason 6 Prostate Cancer?Clinical Validation of the 2005 ISUP Gleason Grading System in a Cohort of Intermediate and High Risk Men Undergoing Radical Prostatectomy Clinical impact of prostate biopsy undergrading in an academic and community setting.Evaluating Prostate Cancer Using Fractional Tissue Composition of Radical Prostatectomy Specimens and Pre-Operative Diffusional Kurtosis Magnetic Resonance Imaging Network diffusion-based analysis of high-throughput data for the detection of differentially enriched modules.Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer.Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome.Should Gleason 6 be labeled as cancer?Evaluation of the 2015 Gleason Grade Groups in a Nationwide Population-based Cohort.Active Surveillance of Prostate Cancer: Use, Outcomes, Imaging, and Diagnostic Tools.A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score Gleason group concordance between biopsy and radical prostatectomy specimens: A cohort study from Prostate Cancer Outcome Registry - Victoria.Single-nucleotide polymorphism rs1058205 of KLK3 is associated with the risk of prostate cancer: A case-control study of Han Chinese men in Northeast China.Biopsy sampling and histopathological markers for diagnosis of prostate cancer.Blinded review of archival radical prostatectomy specimens supports that contemporary Gleason score 6 prostate cancer lacks metastatic potential.Expert consensus document: Semantics in active surveillance for men with localized prostate cancer - results of a modified Delphi consensus procedure.Gleason and Fuhrman no longer make the grade.A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection.Gleason grading challenges in the diagnosis of prostate adenocarcinoma: experience of a single institution.Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancer Changes in prostate cancer grading: Including a new patient-centric grading system.Validation of the 2015 prostate cancer grade groups for predicting long-term oncologic outcomes in a shared equal-access health system.Grading of Prostate Cancer: Past, Present, and Future.Recent advances in prostate cancer pathology: Gleason grading and beyond.Prostate cancer: from Gleason scoring to prognostic grade grouping.Smoking increased the risk of prostate cancer with grade group ≥ 4 and intraductal carcinoma in a prospective biopsy cohort.From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer.Incidental Prostate Adenocarcinoma in Cystoprostatectomy Specimens: Partial Versus Complete Prostate Sampling.

P2860

Q26751983-216ECE87-8122-4AA3-93A1-7C3ED644CA96 Q26752936-37DB13A6-A449-4008-AAC5-1340C0C2EB38 Q28066111-BFF8B183-5534-4628-B620-AAA12763C421 Q28066534-DF0E802A-F27C-4604-ABD4-3FB20689CD6A Q33707381-199DE02C-A236-43F6-9F2D-08829C462924 Q33762501-E1E4CF48-83F0-4589-AA63-DAEBA5142346 Q33874522-0181FAB4-E965-406A-8800-D12F01233E37 Q33980987-71AB4C4A-3E06-4E28-A620-1A16F88209A1 Q34135555-D3965A75-C9E2-43E7-9EE9-EF52DA59B896 Q35602528-FAADD4A5-10A9-4339-AD9E-73372CB65C5A Q35762861-840CFF3C-8EAB-4F6C-A49E-42411E0D87DC Q35885756-5294742D-3931-4A07-A283-8C7E12765B6E Q35941781-8310B33D-58B7-4D3A-9FD6-2652476A8C7C Q36088325-24F77206-3510-420A-8671-3E40D77AE565 Q36161254-6023D73D-0CEC-49F9-969B-781DC9CD8DA9 Q36377961-3A94C2FD-BCC1-45BD-8C13-F966206EF910 Q36511320-F7BAEF2B-1D66-4B07-91CA-B25C1D7ED1FE Q36892392-8DF098EF-6F15-4C9E-82D2-3AB34077507A Q36898434-1098E8DD-6FEB-4449-9975-F3CA57696372 Q36931932-A732B836-95C6-4A94-942B-3AC7CA0038E9 Q37008997-D3D93B5C-43D5-428B-BE84-3122B15B7D63 Q37029385-7CDD95F9-632C-4C2D-B892-0E326E968EEF Q37213040-FFDBDA78-4831-4126-808A-CFB1058810B6 Q37496914-0C835BA7-5BC2-4329-8AF8-57AAE17C5388 Q37696887-21A62F4A-11FB-40A7-A6A2-A034F9EF2DF4 Q38256309-42927F57-DF63-4B65-9B41-506419152024 Q38374235-2166F63D-E51E-4BA8-B631-414B35F90BCA Q38379465-3E995004-C831-4C06-843F-F88823C95BA2 Q38565256-4F04A735-E65C-4857-956F-32F3F440F039 Q38602540-DEC743C2-519B-4FA5-B346-B56A36350B0B Q38632033-2B07A1AE-F263-44B7-AA46-4AEBCB2C5B6C Q38659673-606DA07D-1358-4FED-AB15-AB682FB8F1D8 Q38680873-3F4E7874-2D40-4C7C-8A93-1F23F36E6FCF Q38702259-EDA1292A-780C-4F88-8C6F-929C0F9F9653 Q38732397-6AC4FED8-304A-41D8-8007-879307818790 Q38779933-945D363B-31C4-4B50-BA75-BF49DB4282AA Q38786316-7AFB57FE-794C-409D-86FE-01513E6D3B4E Q38830797-FED273FA-5347-4FEE-B329-31967D7784E5 Q38841964-F27E6579-CB4B-44BD-8271-A0BA5E9DCEC7 Q38851917-86A8A74C-5EC6-4F8D-8216-5A15C02E6303

P2860

Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.

http://www.wikidata.org/entity/Q34610101

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.

@ast

Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.

@en

Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.

@nl

type

label

Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.

@ast

Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.

@en

Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.

@nl

prefLabel

Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.

@ast

Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.

@en

Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.

@nl

P1433

Q34610101-1377BE21-C254-4B31-8FFA-7B0FF4B1EA57

P1476

Q34610101-C44EBBCE-3F1D-4E1B-BE68-C0E6FA85E0C6

P2093

Q34610101-0ACD1833-2CF2-42F8-A72E-86CEA2E547BD

Q34610101-2C2E4FA3-BE1B-4F3A-8EFD-7D3BD0655FFA

Q34610101-C6C89D35-962E-4FCA-A4E6-301A027506FC

P2860

Q34610101-01E651BF-4551-439B-87F7-6E973F5E1B00

Q34610101-0FBA6504-87F6-445A-93B0-420DC150BDAC

Q34610101-2AD76F70-B830-4982-9ED5-6EE97403082B

Q34610101-39C27ABA-6C1B-4CF2-8B1A-5663FF30CF55

Q34610101-6EE1DBA0-D4FA-4259-B67C-8FE7A23EBC4E

Q34610101-926D4538-1406-4585-9FC1-F277A15CDFB8

Q34610101-97AD41DC-82D8-47F1-822B-9F8F77B9B252

Q34610101-B712B28E-12A8-449A-A644-99BA2797C2D8

Q34610101-C1449089-A4E7-4360-A5DF-F0691F3B1C19

Q34610101-C4655F57-C858-46E0-A13B-E035EBEB2157

P304

Q34610101-BA42AB06-B2B0-4E89-B124-EF0CA6BF4324

P31

Q34610101-35771F59-3C3E-4544-ABF6-099404C570A9

P356

Q34610101-C120DE1C-5793-4AF4-9341-3B4F960333FD

P433

Q34610101-C27F264A-D8D2-4FCD-B923-760B79E95984

P478

Q34610101-B2E617C4-520B-4E80-933E-F3563BF97B36

P50

Q34610101-FE920117-D7AF-4FD8-A15B-E6E9279F230A

P577

Q34610101-0CEE8762-27F5-4C3E-A58F-7EB31B7EEC1A

P698

Q34610101-5978B0D3-745F-49BC-8061-8ACE7654BF65

P932

Q34610101-1051D440-CA06-49F7-A655-9EA343805F0B

P356

J.1464-410X.2012.11611.X

P1433

BJU International

P1476

Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.

@en

P2093

Jonathan I Epstein

http://www.w3.org/2001/XMLSchema#string

Patrick C Walsh

http://www.w3.org/2001/XMLSchema#string

Phillip M Pierorazio

http://www.w3.org/2001/XMLSchema#string

P2860

Risk stratification of men with Gleason score 7 to 10 tumors by primary and secondary Gleason score: results from the SEARCH database.

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.

Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading.

The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies.

A pathological reassessment of organ-confined, Gleason score 6 prostatic adenocarcinomas that progress after radical prostatectomy.

Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores?

Grading of invasive cribriform carcinoma on prostate needle biopsy: an interobserver study among experts in genitourinary pathology.

Digital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome.

Tertiary Gleason patterns and biochemical recurrence after prostatectomy: proposal for a modified Gleason scoring system.

Comparison of biochemical relapse-free survival between primary Gleason score 3 and primary Gleason score 4 for biopsy Gleason score 7 prostate cancer.

P304

753-760

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1464-410X.2012.11611.X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23464824

http://www.w3.org/2001/XMLSchema#string

P932

3978145

http://www.w3.org/2001/XMLSchema#string